Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
The Vestibular System01:29

The Vestibular System

45.4K
The vestibular system is a set of inner ear structures that provide a sense of balance and spatial orientation. This system is comprised of structures within the labyrinth of the inner ear, including the cochlea and two otolith organs—the utricle and saccule. The labyrinth also contains three semicircular canals—superior, posterior, and horizontal—that are oriented on different planes.
45.4K
Neural Regulation01:37

Neural Regulation

45.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.1K
Equilibrium and Balance01:15

Equilibrium and Balance

8.2K
The inner ear assumes dual functionalities of auditory perception and equilibrium maintenance. The vestibule is the organ responsible for balance. This organ contains mechanoreceptors, specifically hair cells, endowed with stereocilia, which aid in deciphering information regarding the position and motion of our heads. Two intrinsic components, the utricle and saccule, help perceive head position, while the semicircular canals track head movement. Neurological messages initiated in the...
8.2K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists01:28

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

1.9K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional near-infrared spectroscopy (fNIRS) biomarkers of tinnitus severity within tinnitus subtypes.

Hearing research·2026
Same author

Correction: Differential impact of repetitive transcranial magnetic stimulation on alzheimer's disease symptomology: evidence from electrovestibulography.

Cognitive neurodynamics·2025
Same author

Differential Impact of Repetitive Transcranial Magnetic Stimulation on Alzheimer's Disease Symptomology: Evidence from Electrovestibulography Does repetitive transcranial magnetic stimulation treatment alter Alzheimer's disease symptomology? a clue to show who will benefit.

Cognitive neurodynamics·2025
Same author

Objective assessment of tinnitus laterality.

PloS one·2025
Same author

Surface Versus Penetrative rTMS Stimulation May Be More Effective for AD Patients with Cerebrovascular Disease.

Neuroscience insights·2025
Same author

Cochlear implant induced changes in cortical networks associated with tinnitus severity.

Journal of neural engineering·2024

Related Experiment Video

Updated: Apr 14, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.6K

Parkinson's disease: disturbed vestibular function and levodopa.

Brian J Lithgow1, Mehrnaz Shoushtarian2

  • 1Monash Alfred Psychiatry Research Centre, Monash University Central Clinical School and the Alfred Hospital, 4th Floor, 607St Kilda Rd, Melbourne, Victoria, Australia 3004; Diagnostic and Neurosignal Processing Research Laboratory, Monash University, Wellington Rd, Clayton, Victoria, Australia 3180; Diagnostic and Neurosignal Processing Research Laboratory, University of Manitoba, Riverview Health Centre, 1 Morley St, Winnipeg, MB, Canada R3L 2P4.

Journal of the Neurological Sciences
|April 23, 2015
PubMed
Summary

Levodopa impacts central postural control in Parkinson's disease (PD). Electrovestibulography (EVestG) revealed distinct vestibular function differences in PD patients, both with and without medication.

Keywords:
BiomarkerElectrovestibulographyLevodopaParkinson’s diseasePostural controlSymptomatology

More Related Videos

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.7K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

19.3K

Related Experiment Videos

Last Updated: Apr 14, 2026

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.6K
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.7K
Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model
05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

19.3K

Area of Science:

  • Neuroscience
  • Biomedical Engineering
  • Vestibular System Research

Background:

  • Levodopa is a primary treatment for Parkinson's disease (PD), primarily targeting central motor control.
  • Postural instability is a significant symptom in PD, affecting patient mobility and quality of life.
  • Electrophysiological biomarkers are needed to objectively assess postural control deficits.

Purpose of the Study:

  • To investigate the effects of Levodopa on central postural control using electrophysiological measures.
  • To identify specific biomarkers from Electrovestibulography (EVestG) data indicative of PD and Levodopa's influence.
  • To differentiate postural control in PD patients before and after Levodopa administration.

Main Methods:

  • Extracted sensory oto-acoustic features from EVestG data in 20 healthy controls and 38 PD patients (20 pre-Levodopa, 18 post-Levodopa).
  • Utilized a single tilt stimulus in the pitch plane to elicit responses.
  • Employed unbiased cross-validation for classification accuracy assessment.

Main Results:

  • Achieved high classification accuracies (79%-88%) distinguishing between control, PDlowmed (pre-Levodopa), and PDmed (post-Levodopa) groups using EVestG features.
  • Identified significant correlations between one EVestG feature and the Modified Hoehn and Yahr PD staging scale.
  • Demonstrated that vestibular function is disturbed in PD, irrespective of Levodopa medication, and these states are distinguishable.

Conclusions:

  • EVestG-derived features serve as effective biomarkers for assessing postural control deficits in Parkinson's disease.
  • Levodopa medication influences vestibular function in PD patients, suggesting effects beyond central motor control.
  • Disturbed vestibular function is present in both medicated and unmedicated PD states, indicating potential peripheral and central impacts.